DA32 Life Science Tech Acquisition Corp. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
DA32 Life Science Tech Acquisition Corp. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2021 to Q1 2023.
  • DA32 Life Science Tech Acquisition Corp. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending March 31, 2023 was $1.15M.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $1.15M +$1.46M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q3 2022 $577K +$849K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q1 2022 -$303K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 -$271K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.